Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Asclepes Research Centers PC

Neither a doctor nor a teaching hospital

Research payments

$1,507,345

181 payments

Through program year 2025, Asclepes Research Centers PC is reported as receiving $1,507,345 in research payments, across 181 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $46,774 15
2024 Research $657,013 59
2023 Research $133,206 23
2022 Research $242,611 23
2021 Research $280,566 15
2020 Research $57,739 10
2019 Research $89,436 36

Breakdown

Who paid Research payments · program years 2019–2025
  1. AbbVie, Inc. $651,501 76 payments
  2. Otsuka Pharmaceutical Development & Commercialization, Inc. $358,838 18 payments
  3. Hoffmann-La Roche Limited $217,098 10 payments
  4. Pfizer Inc. $115,772 23 payments
  5. Allergan Inc. $78,723 23 payments
  6. Guerbet LLC $33,095 4 payments
  7. EMD Serono, Inc. $12,500 1 payment
  8. Eli Lilly and Company $11,709 2 payments
  9. Mallinckrodt LLC $7,127 2 payments
  10. Genentech, Inc. $6,981 3 payments
Studies the money was for Research payments · program years 2019–2025
  1. Acute Schizophrenia Study $217,098 10 payments
  2. Study to Assess Adverse Events Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer s Disease $168,398 5 payments
  3. Study to Assess Adverse Events Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimers Disease $164,911 3 payments
  4. A Phase 3, Multicenter, Randomized, Double-Blind Trial of Fixed-Dose Brexpiprazole As Combination Therapy With Sertraline in the Treatment of Adults With Post-Traumatic Stress Disorder $117,988 3 payments
  5. A Phase 2 Randomized Doubleblind Doubledummy Placebocontrolled Doseranging Dosefinding Parallel Group Study to Assess Efficacy and Safety of Pf06865571 Dgat2i Alone and When Coadministered With Pf05221304 Acci in Adult Participants With Biopsyconfirmed Nonalcoholic Steatohepatitis and Fibrosis Stage 2 Or 3 $62,809 15 payments
  6. Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimers Disease $58,270 4 payments
  7. A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Avp-786 (Deudextromethorphan Hydrobromide [D6 Dm]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimers Type $56,602 2 payments
  8. A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Avp-786 (Deuterated [D6]-Dextromethorphan Hydrobromide [D6-Dm]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimers Type $54,483 3 payments
  9. A Phase 3, Multicenter, Randomized, Double-Blind Trial of Fixed-Dose Brexpiprazole As Combination Therapy With Sertraline in the Treatment of Adults With Post-Traumatic Stress Disorder $45,680 1 payment
  10. A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine $43,640 15 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record